Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 2
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (505)
- Volume 18, 2024 (9)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 1, 2007
Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine
Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, Silvia Cucchi, Jesús Vázquez, Leonard Robinson, et al
Biologics: Targets and Therapy 2007, 1:173-181
Published Date: 15 November 2007
Infliximab in the treatment of ankylosing spondylitis
Rebecca Grainger, Andrew A Harrison
Biologics: Targets and Therapy 2007, 1:163-171
Published Date: 15 November 2007
Biological targets for isatin and its analogues: Implications for therapy
Alexei Medvedev, Olga Buneeva, Vivette Glover
Biologics: Targets and Therapy 2007, 1:151-162
Published Date: 15 November 2007
Dishing the dirt on asthma: What we can learn from poor hygiene
Catherine de Lara, Alistair Noble
Biologics: Targets and Therapy 2007, 1:139-150
Published Date: 15 November 2007
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
Ruben A Mesa
Biologics: Targets and Therapy 2007, 1:129-138
Published Date: 15 November 2007
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance
Giovanni Martinelli, Ilaria Iacobucci, Simona Soverini, Francesca Palandri, Fausto Castagnetti et al
Biologics: Targets and Therapy 2007, 1:121-127
Published Date: 15 November 2007
Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphoma
Biree Andemariam, John P Leonard
Biologics: Targets and Therapy 2007, 1:113-120
Published Date: 15 November 2007
The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT
Andreas Koster, Karl-Georg Fischer, Sebastian Harder, Fritz Mertzlufft
Biologics: Targets and Therapy 2007, 1:105-112
Published Date: 15 November 2007
Drug focus: adalimumab in the treatment of moderate to severe psoriasis
Gino A Vena
Biologics: Targets and Therapy 2007, 1:93-103
Published Date: 15 November 2007
Cetuximab in the management of colorectal cancer
Heinz-Josef Lenz
Biologics: Targets and Therapy 2007, 1:77-91
Published Date: 15 November 2007
Editorial: Evidence is steadily accumulating that ... || FREE PAPER ||
Sanjay Awasthi
Biologics: Targets and Therapy 2007, 1:75-76
Published Date: 15 November 2007